ConductScience.org, home

Paper38498331

Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes.

Shang Y and 7 others. Diabetes Care, 2024. Cited by 53 papers, by iCite.

Cite this record

ConductScience Library. Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes. Papers, record 38498331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38498331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes.
PubMed
Journal
Diabetes Care
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
7.31, provisional
iCite
Revised in PubMed
2026-06-25
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shang YYinghttps://orcid.org/0000-0002-1496-1799
2Grip ETEmilie Toresson
3Modica AAngelo
4Skröder HHelena
5Ström OOskar
6Ntanios FFady
7Gudbjörnsdottir SSoffia
8Hagström HHannes

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
Metabolic SyndromeMajor topic
Humans
Male
Middle Aged
Female
Aged
Sweden
Liver Diseases
Risk Factors

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
The Swedish Research CouncilPubMed
Mag-TarmFonden, Swedish Gastroenterology SocietyPubMed
PfizerPubMed
Karolinska InstitutetPubMed

Source PubMed

Download CSV of grants

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132960654Validity of administrative codes associated with cirrhosis in Sweden.Scand J Gastroenterol2020https://conductscience.org/library/papers/32960654PubMed
231009793Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes.Clin Gastroenterol Hepatol2019https://conductscience.org/library/papers/31009793PubMed
312055590Diabetes increases the risk of acute hepatic failure.Gastroenterology2002https://conductscience.org/library/papers/12055590PubMed
424890439Mortality from chronic liver diseases in diabetes.Am J Gastroenterol2014https://conductscience.org/library/papers/24890439PubMed
535421424Taking a risk-based approach to testing for liver disease in primary care, a step in the right direction.J Hepatol2022https://conductscience.org/library/papers/35421424PubMed
621658213External review and validation of the Swedish national inpatient register.BMC Public Health2011https://conductscience.org/library/papers/21658213PubMed
716176206The gap between guidelines and reality: Type 2 diabetes in a National Diabetes Register 1996-2003.Diabet Med2005https://conductscience.org/library/papers/16176206PubMed
828803953Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.J Hepatol2017https://conductscience.org/library/papers/28803953PubMed
936626630The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.Hepatology2023https://conductscience.org/library/papers/36626630PubMed
1019504049The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research.Eur J Epidemiol2009https://conductscience.org/library/papers/19504049PubMed
1135798021The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.Lancet Gastroenterol Hepatol2022https://conductscience.org/library/papers/35798021PubMed
1235371259Bidirectional Association between Hypertension and NAFLD: A Systematic Review and Meta-Analysis of Observational Studies.Int J Endocrinol2022https://conductscience.org/library/papers/35371259PubMed
1318767000The completeness of the Swedish Cancer Register: a sample survey for year 1998.Acta Oncol2009https://conductscience.org/library/papers/18767000PubMed
1433724511Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease.Hepatology2021https://conductscience.org/library/papers/33724511PubMed
1525550056Diabetes care--improvement through measurement.Diabetes Res Clin Pract2014https://conductscience.org/library/papers/25550056PubMed
1628342948Waist/Hip Ratio Better Predicts Development of Severe Liver Disease Within 20 Years Than Body Mass Index: A Population-based Cohort Study.Clin Gastroenterol Hepatol2017https://conductscience.org/library/papers/28342948PubMed
1716341841Impact of metabolic syndrome criteria on cardiovascular disease risk in people with newly diagnosed type 2 diabetes.Diabetologia2006https://conductscience.org/library/papers/16341841PubMed
1819805654
Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.
Circulation2009https://conductscience.org/library/papers/19805654PubMed
1922792295The PNPLA3 rs738409 G-allele associates with reduced fasting serum triglyceride and serum cholesterol in Danes with impaired glucose regulation.PLoS One2012https://conductscience.org/library/papers/22792295PubMed
207662841Applying Cox regression to competing risks.Biometrics1995https://conductscience.org/library/papers/7662841PubMed

See all 37 referencesDownload CSV of references

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
42771812Association Between Visceral Adiposity Index and Metabolic Syndrome and Its Components: Evidence From the PERSIAN Guilan Cohort Study.Endocrinol Diabetes Metab2026https://conductscience.org/library/papers/42771812PubMed
42671251Upcoming therapies for steatotic liver disease: Translating breakthroughs into clinical practice.J Intern Med2026https://conductscience.org/library/papers/42671251PubMed
42639235Metabolic Syndrome: From Mechanisms to Therapeutic Interventions.MedComm (2020)2026https://conductscience.org/library/papers/42639235PubMed
42603840The liver in diabetes: current state and future perspectives.Diabetologia2026https://conductscience.org/library/papers/42603840PubMed
42588152The MASLD-Cardio-Oncology Triangle: Dietary Patterns, Metabolic Remodelling and Implications for Cancer Therapy Tolerance.Nutrients2026https://conductscience.org/library/papers/42588152PubMed
42562881Screening and diagnosis of liver disease in diabetes: a guide and evidence-based assessment.Diabetologia2026https://conductscience.org/library/papers/42562881PubMed
42334798Peripheral and Autonomic Diabetic Neuropathy and Their Additive Risk of Major Adverse Liver Outcomes in Type 2 Diabetes.Adv Ther2026https://conductscience.org/library/papers/42334798PubMed
42216178A culturally adapted online Mediterranean diet intervention for metabolic dysfunction-associated steatotic liver disease (TIMA): study protocol for a randomized controlled trial.Trials2026https://conductscience.org/library/papers/42216178PubMed
41687818Longitudinal changes in cardiometabolic risk factors are associated with changes in liver stiffness in adults with MASLD.J Hepatol2026https://conductscience.org/library/papers/41687818PubMed
41645665Prevalence and risk factors for metabolic dysfunction-associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort.J Intern Med2026https://conductscience.org/library/papers/41645665PubMed
41630354Associations of Albuminuria and Metabolic Syndrome Traits With Fracture Risk in Patients With Type 2 Diabetes: A Population-Based Cohort Study.J Cachexia Sarcopenia Muscle2026https://conductscience.org/library/papers/41630354PubMed
41431489Correlation Between the Levels of Fasting and Postprandial ApoB48 with Metabolic Syndrome: A Cross-Sectional Study.Diabetes Metab Syndr Obes2025https://conductscience.org/library/papers/41431489PubMed
41405814Enhancing the interpretation of diabetes-related risk in ALD-ACLF: a methodological perspective.Hepatol Int2026https://conductscience.org/library/papers/41405814PubMed
41368122Cytokeratin 18 fragment is associated with steatosis-associated fibrosis estimator score and lipid in patients with steatotic liver disease.World J Hepatol2025https://conductscience.org/library/papers/41368122PubMed
41321337Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease with Clinically Significant Fibrosis in Obese Patients with Type 2 Diabetes Mellitus - China, 2017-2024.China CDC Wkly2025https://conductscience.org/library/papers/41321337PubMed
41262775Temporal comorbidity patterns preceding MASLD-related major adverse liver outcomes: a nationwide population-based case-control study in Sweden.BMJ Public Health2025https://conductscience.org/library/papers/41262775PubMed
41190151Cardiovascular-kidney-metabolic progression associated with major adverse liver outcomes: mediating roles of plasma metabolites.Front Nutr2025https://conductscience.org/library/papers/41190151PubMed
41058240Relative efficacy of GLP-1 and GLP-1/GIP receptor agonists in the prevention of alcohol-use disorders using a target trial emulation approach.Diabetes Obes Metab2026https://conductscience.org/library/papers/41058240PubMed
40980971Target Trial Emulations of GLP-1 and Dual GLP-1/GIP Agonists to Reduce Major Adverse Liver Outcomes in Type 2 Diabetes.Liver Int2025https://conductscience.org/library/papers/40980971PubMed
40775615Predictive factors for metabolic syndrome in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).BMC Gastroenterol2025https://conductscience.org/library/papers/40775615PubMed

See all 33 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38498331

GET https://conductscience.org/api/papers/v1/38498331/references?page=2